Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Lenalidomide in Combination With Microtransplantation as Post-remission Therapy in AML

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02255162
Recruitment Status : Terminated (Slow Accrual)
First Posted : October 2, 2014
Last Update Posted : August 18, 2017
Sponsor:
Collaborator:
Celgene Corporation
Information provided by (Responsible Party):
Amir Fathi, Massachusetts General Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : December 2016
Actual Study Completion Date : December 2016